Pharmacokinetics and pharmacodynamics of bioactive compounds in Penyanqing preparation in THP-1 inflammatory cells induced by Lipopolysaccharide.

Abstract

BACKGROUND:

Penyanqing (PYQ), a traditional Chinese medicine (TCM), has a good clinical efficacy for the treatment of pelvic inflammatory disease (PID). Previously, researches on its anti-inflammatory effect and mechanism in vitro, in silico, and in vivo have been reported by our team. However, the interrelationship between the anti-inflammatory activity and the active compounds in PYQ are not clear. Here, the pharmacokinetics-pharmacodynamics (PK-PD) study was carried out for more proper clinical use.

METHODS:

The plasma concentrations of salvianolic acid B (SAB), protocatechualdehyde (PRO), paeoniflorin (PE), astilbin (AST), ferulic acid (FE), and chlorogenic acid (CH) in SD rats after PYQ administration were determined by a selective and rapid HPLC-MS/MS method. In addition, the PK-PD on cell model was used to explore the relationship between the plasma concentration and inflammatory biomarkers (TNF-α, IL-1β).

RESULTS:

The results of this study showed that the six components could reach the peak blood concentration within 0.29 h, indicating the rapid absorption of it. The eliminations of AST, CH, FE, PE, and PRO were relatively fast due to their mean residence times (MRTs) within 3 h, while the elimination of SAB was slower (MRT 5.67 ± 0.66 h). Combined with a THP-1 cell model, there was a significant correlation between inflammatory factors and component plasma concentrations with correlation coefficients in the range of -0.9--0.746. Correspondingly, the drug-containing plasma obtained at 0.25 h point exhibited the best inhibition effect on production of IL-1β and TNF-α in LPS-induced THP-1 cells.

CONCLUSION:

The six main components in PYQ could be quickly absorbed, and there was a potential good correlation between their pharmacokinetics and the pharmacodynamics of PYQ.

• Authors: Linna Gong, Zhishuo Miao, Li Zhang, Birui Shi, Zuoqi Xiao, Panzi Qiu, Menghua Liu, Wei Zou
• Journal: BMC complementary medicine and therapies (BMC Complement Med Ther) Vol. 22 Issue 1 Pg. 323 (Dec 06 2022) ISSN: 2662-7671 [Electronic] England
• PMID: 36474249 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Lipopolysaccharides
• Tumor Necrosis Factor-alpha

Topics

• Animals
• Rats
• Humans
• Rats, Sprague-Dawley
• THP-1 Cells
• Lipopolysaccharides
• Tumor Necrosis Factor-alpha
• Tandem Mass Spectrometry